Table 2.
PLA | GLU | |||||
---|---|---|---|---|---|---|
IgA (μg/ml) | ||||||
PRE | 153.31 | ± | 102.12 | 158.31 | ± | 77.70 |
POST | 183.93 | ± | 102.27 | 242.37 | ± | 172.17* |
TP (mg/ml) | ||||||
PRE | 2.10 | ± | 0.97 | 2.04 | ± | 0.74 |
POST | 2.17 | ± | 0.94 | 2.02 | ± | 0.97 |
IgA/TP (μg/mg) | ||||||
PRE | 84.97 | ± | 42.80 | 77.77 | ± | 35.28 |
POST | 98.01 | ± | 43.38 | 115.34 | ± | 66.99** |
NO (μmol/l) | ||||||
PRE | 154.6 | ± | 167.1 | 156.5 | ± | 153.5 |
POST | 299.7 | ± | 522.5 | 352.2 | ± | 426.6** |
Incidence of URTI (ratio) | 12 | 5† |
TP, total protein; GLU, L-glutamine group; PLA, placebo group.
Values are mean ± SD.
*p < 0.05, **p < 0.01, significantly different from PRE in each group.
†p < 0.05, significantly lower than PLA.